Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;10(1):2010-2015.
doi: 10.1080/22221751.2021.1994356.

Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy

Affiliations

Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy

Andreina Baj et al. Emerg Microbes Infect. 2021 Dec.

Abstract

The SARS-CoV-2 variant of concern (VOC) "Delta" is currently defined by PANGOLIN as a cluster of 33 different AY sublineages. Delta (in particular B.1.617.2) is largely and rapidly replacing the Alpha VOC as the dominant clade in most countries. To date, variations in the Spike protein of the Delta VOC have largely been limited. We report here the results of a genomic surveillance programme from Northern Italy. We identified several Delta sublineages harbouring mutations previously reported in GISAID at extremely low frequencies and in different combinations. Two patients (one of them vaccinated) tested positive for a Delta sublineage harbouring S71F, T250I, T572I and K854N. More patients tested positive for G769 V plus C1248F, A352S, and R158G and C1248F, respectively. Genomic surveillance of Delta variants should be encouraged to anticipate immune escape and deploy countermeasures.

Keywords: C1238F; Delta; G769V; K854N; S71F; SARS-CoV-2; T250I; T572I.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Simplified linear representation of the delta VOC subclades currently reported by WHO.

References

    1. Baral P, Bhattarai N, Hossen ML, et al. Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion. Biochem Biophys Res Commun. 2021;574:14–19. - PMC - PubMed
    1. Planas D, Veyer D, Baidaliuk A, et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021;596(7871):276–280. - PubMed
    1. Baj A, Novazzi F, Ferrante FD, et al. Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy. J Med Virol. 2021;93(12):6460–6461. - PMC - PubMed
    1. Thornlow B, Hinrichs AS, Jain M, et al. A new SARS-CoV-2 lineage that shares mutations with known variants of concern is rejected by automated sequence repository quality control. bioRxiv. 2021, 2021.04.05.438352.
    1. Chaudhari A, Kumar D, Joshi DM, et al. E156/G and Arg158, Phe-157/del mutation in NTD of spike protein in B.1.167.2 lineage of SARS-CoV-2 leads to immune evasion through antibody escape. bioRxiv. 2021, 2021.06.07.447321.

Substances